The value of screening for DPD activity in all patients treated with fluoropyrimidines.
The value of screening for DPD activity in all patients treated with fluoropyrimidines. 5-Fluorouracile breast cancer capecitabine DPD deficiency Maud MAILLARD – t team DIAD Dose-Individualization of Anti-cancer Drugs, CRCT Fluoropyrimidines (mainly...A new immunotherapy strategy for melanoma patients.
A new immunotherapy strategy for melanoma patients. Anti-TNF Anti-PD-1 Anti-CTLA-4 melanoma Clinical trial Bruno Ségui a Nicolas Meyer – Equipe “MELASPHINX : Sphingolipid metabolism: From basic mechanisms to immunotherapy Melanoma is a skin cancer with a poor...
The cell signalling enzymes PI3Kalpha and PI3Kβ play major roles in the body.
The cell signalling enzymes PI3Kalpha and PI3Kβ play major roles in the body. Cell signalling Cancer Oncogenic signalling tumour suppressors PI3K/AKT/mTOR Dr Julie Guillermet-Guibert – CRCT team : SigDYN : Integration of cellular signals & PI3K class I, II,...
The PACMINE project is selected for the Toulouse Cancer Health Foundation’s call for funds
The PACMINE project is selected for the Toulouse Cancer Health Foundation’s call for funds The PACMINE project, led by Julie Guillermet-Guibert, Research Officer at the CRCT (Toulouse Cancer Research Centre), and Elisa Boutet-Robinet, Researcher at Toxalim and...